Directors of NCI-designated cancer centers are facing a new set of challenges in a polarizing, high-stakes election year.
Christopher Li, the Helen G. Edson Endowed Chair for Breast Cancer Research at Fred Hutchinson Cancer Center, understands what it means to be an underrepresented minority at each stage of his academic career.
Latino patients with cancer face a challenging survivorship journey. Find new ways to address these challenges at UT Health San Antonio’s webinar, “How to Support Latino Cancer Survivors,” at 11 a.m. Central Time on Monday, July 15.
The American Cancer Society has published a first-of-its-kind study, “Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer or Gender-nonconforming (LGBTQ+)”.
FDA Oncology Center of Excellence has formed the OCE Equity Program.
Ray Blind, Ingram Assistant Professor of Cancer Research, was named associate director for diversity, equity, and inclusion at Vanderbilt-Ingram Cancer Center.
As a new deputy director at UPMC Hillman Cancer Center, Monica Baskin has assumed a level of responsibility that is unusual, if not unprecedented, for a population scientist at an NCI-designated cancer center.
Vittoria Bocchi, Julia Brunner, Melissa Yao, Tzippora Chwat-Edelstein named 2024 Kravis WiSE fellows
From left to right: Vittoria Bocchi, Melissa Yao, Julia Brunner, Tzippora Chwat-EdelsteinVittoria Bocchi, Julia Brunner, Melissa Yao, and Tzippora Chwat-Edelstein, four Sloan Kettering Institute researchers, were named 2024 Marie-Josée Kravis Women in Science Endeavor, or Kravis WiSE, fellowship grant recipients.
Regeneron Pharmaceuticals Inc. and Society for Science today announced the top 40 finalists in this year’s Regeneron Science Talent Search, the nation’s oldest and most prestigious science and math competition for high school seniors.
Sheldon L. Holder knew he wanted to pursue a career in medicine in the second grade, thanks to a career day at his school on the island of Bermuda.
